Sarah Heerboth

4.2k total citations · 2 hit papers
14 papers, 3.2k citations indexed

About

Sarah Heerboth is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, Sarah Heerboth has authored 14 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 3 papers in Pediatrics, Perinatology and Child Health and 3 papers in Oncology. Recurrent topics in Sarah Heerboth's work include Epigenetics and DNA Methylation (8 papers), Histone Deacetylase Inhibitors Research (5 papers) and Pregnancy and preeclampsia studies (2 papers). Sarah Heerboth is often cited by papers focused on Epigenetics and DNA Methylation (8 papers), Histone Deacetylase Inhibitors Research (5 papers) and Pregnancy and preeclampsia studies (2 papers). Sarah Heerboth collaborates with scholars based in United States. Sarah Heerboth's co-authors include Sibaji Sarkar, K Lapińska, Shannon Byler, Genevieve Housman, Mckenna Longacre, Meghan Leary, Amber Willbanks, Kimberly L. Moulton, Kathryn Haskins and Troy D. Moon and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Cancers.

In The Last Decade

Sarah Heerboth

13 papers receiving 3.2k citations

Hit Papers

Drug Resistance in Cancer: An Overview 2014 2026 2018 2022 2014 2015 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah Heerboth United States 11 2.0k 983 710 318 283 14 3.2k
K Lapińska United States 8 1.8k 0.9× 928 0.9× 647 0.9× 307 1.0× 261 0.9× 8 3.0k
Shannon Byler United States 7 1.8k 0.9× 971 1.0× 689 1.0× 319 1.0× 273 1.0× 9 3.0k
Genevieve Housman United States 10 1.7k 0.9× 918 0.9× 665 0.9× 295 0.9× 255 0.9× 17 2.9k
Mckenna Longacre United States 9 1.7k 0.9× 935 1.0× 646 0.9× 314 1.0× 269 1.0× 16 3.0k
Sibaji Sarkar United States 19 2.5k 1.2× 1.1k 1.1× 818 1.2× 349 1.1× 320 1.1× 47 4.0k
Bikul Das United States 23 1.6k 0.8× 922 0.9× 628 0.9× 391 1.2× 332 1.2× 54 3.3k
Reza Bayat Mokhtari Canada 16 1.6k 0.8× 839 0.9× 808 1.1× 343 1.1× 552 2.0× 35 3.1k
Neil Vasan United States 10 1.4k 0.7× 637 0.6× 592 0.8× 378 1.2× 333 1.2× 26 2.5k
Caitriona Holohan United Kingdom 13 2.6k 1.3× 1.3k 1.3× 823 1.2× 602 1.9× 404 1.4× 18 4.1k
Erika Di Zazzo Italy 22 1.4k 0.7× 523 0.5× 578 0.8× 368 1.2× 525 1.9× 44 2.9k

Countries citing papers authored by Sarah Heerboth

Since Specialization
Citations

This map shows the geographic impact of Sarah Heerboth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Heerboth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Heerboth more than expected).

Fields of papers citing papers by Sarah Heerboth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Heerboth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Heerboth. The network helps show where Sarah Heerboth may publish in the future.

Co-authorship network of co-authors of Sarah Heerboth

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Heerboth. A scholar is included among the top collaborators of Sarah Heerboth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Heerboth. Sarah Heerboth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Blue, Nathan R., Amanda A. Allshouse, Sarah Heerboth, et al.. (2022). Derivation and assessment of a sex-specific fetal growth standard. The Journal of Maternal-Fetal & Neonatal Medicine. 35(25). 9913–9921. 1 indexed citations
2.
Heerboth, Sarah, et al.. (2021). Clinical Implications of Second and Third Trimester Surveillance Ultrasounds of Growth-Restricted Fetuses. American Journal of Perinatology Reports. 11(4). e132–e136.
4.
Lapińska, K, et al.. (2018). Cancer Progenitor Cells: The Result of an Epigenetic Event?. Anticancer Research. 38(1). 1–6. 16 indexed citations
5.
Leary, Meghan, Sarah Heerboth, K Lapińska, & Sibaji Sarkar. (2018). Sensitization of Drug Resistant Cancer Cells: A Matter of Combination Therapy. Cancers. 10(12). 483–483. 125 indexed citations
6.
Lapińska, K, Genevieve Housman, Shannon Byler, et al.. (2016). The Effects of Histone Deacetylase Inhibitor and Calpain Inhibitor Combination Therapies on Ovarian Cancer Cells. Anticancer Research. 36(11). 5731–5742. 21 indexed citations
7.
Longacre, Mckenna, Genevieve Housman, Meghan Leary, et al.. (2016). A Comparative Analysis of Genetic and Epigenetic Events of Breast and Ovarian Cancer Related to Tumorigenesis. International Journal of Molecular Sciences. 17(5). 759–759. 42 indexed citations
8.
Willbanks, Amber, Meghan Leary, Sarah Heerboth, et al.. (2016). The Evolution of Epigenetics: From Prokaryotes to Humans and Its Biological Consequences. SHILAP Revista de lepidopterología. 8. 25–36. 49 indexed citations
9.
Heerboth, Sarah, Genevieve Housman, Meghan Leary, et al.. (2015). EMT and tumor metastasis. SHILAP Revista de lepidopterología. 4(1). 6–6. 594 indexed citations breakdown →
10.
Housman, Genevieve, Shannon Byler, Sarah Heerboth, et al.. (2014). Drug Resistance in Cancer: An Overview. Cancers. 6(3). 1769–1792. 1906 indexed citations breakdown →
11.
Byler, Shannon, Sarah Heerboth, Meghan Leary, et al.. (2014). Genetic and epigenetic aspects of breast cancer progression and therapy.. PubMed. 34(3). 1071–7. 160 indexed citations
12.
Heerboth, Sarah, et al.. (2014). Use of Epigenetic Drugs in Disease: An Overview. SHILAP Revista de lepidopterología. 6. 9–19. 220 indexed citations
14.
Heerboth, Sarah, et al.. (2012). Anti-breast cancer effects of histone deacetylase inhibitors and calpain inhibitor.. PubMed. 32(7). 2523–9. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026